Use of Prescription Assistance Programs After the Affordable Health Care Act

Journal of Managed Care & Specialty Pharmacy
Ghazala KhanSarah Lerchenfeldt

Abstract

Insurance coverage in the United States seems to be in a state of unrest. The 2010 passage of the Patient Protection and Affordable Health Care Act (ACA) extended health insurance coverage to roughly 32 million people. An increase in the number of people with health insurance benefits raised the question of whether prescription assistance programs (PAPs) would still be used after ACA implementation. To evaluate the use of PAPs following the implementation of the ACA insurance mandate. Health insurance was not required by the ACA until January 2014, so we retrospectively examined the use of drug company-sponsored PAPs before and after the ACA implementation. Since each PAP had its own qualifying criteria, any person who used a PAP through the assistance of NeedyMeds and its PAPTracker between the years of 2011 and 2016 were included for analysis. Data were pulled by NeedyMeds from the PAPTracker software, which produces completed PAP applications from drug manufacturer forms for PAPs. The number of PAP orders, number of unique patient orders, and annual patient prescription savings were assessed. Between 2011 and 2013, there was an average of 4.2 annual PAP orders per patient; however, annual PAP orders decreased to 3.1 per pati...Continue Reading

References

Nov 29, 2007·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Usha R RanjiHongjian Yu
May 6, 2009·Health Affairs·Niteesh K ChoudhryWilliam H Shrank
Jun 17, 2014·The Nurse Practitioner·Christine R Shaw
Dec 4, 2015·Health Affairs·Anne B MartinUNKNOWN National Health Expenditure Accounts Team
Mar 31, 2016·Journal of Managed Care & Specialty Pharmacy·Mason H BurleySamuel Selinger
Jul 12, 2016·JAMA : the Journal of the American Medical Association·Barack Obama
Aug 24, 2016·JAMA : the Journal of the American Medical Association·Aaron S KesselheimAmeet Sarpatwari
Mar 28, 2017·Journal of Managed Care & Specialty Pharmacy·Leah L ZulligS Yousuf Zafar

❮ Previous
Next ❯

Citations

Dec 28, 2019·Journal of Managed Care & Specialty Pharmacy·Stephanie S BethayPhilip A Schwieterman
Jun 25, 2019·Journal of Managed Care & Specialty Pharmacy·Joelle L Farano, Huda-Marie Kandah
Apr 21, 2020·The Journal of Dermatological Treatment·Erin K CollierVivian Y Shi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.